ROMA (ITALPRESS) – Health and health have been at the centre of the eighth edition of “Investing for Life Health Summit”. The event, organized by MSD Italia at the MAXXI Museum in Rome, represents an important event that brings together illustrious representatives of the political-institutional and academic world, experts of the medical-scientific community and Associations of Patients to give life to a comparison on hot topics related to health policy, access to innovation and investments in health. The debate confirms the need to continue to focus on the policy agenda on health and encourage investment as much as possible in support of innovation which pharmaceutical companies are promoting. “Today’s appointment is important because we want to bring to civil attention some fundamental issues: the first is that of the competitiveness of the pharmaceutical sector with the revision of the single text of the pharmaceutical; the second is to return the value to innovative drugs, through an accurate analysis process following thresholds of international evaluations; the third is to accelerate access to innovation for all patients, not only at national level but also at regional level. We want to consider prevention as an investment through immunization and screening”, the proposals of President and CEO of MSD Italia Nicoletta Luppi. The survey data, conducted by Euromedia Research, confirm the waiting lists as the main problem of the SSN (58% of respondents vs 62% in 2024) followed by other priorities perceived by citizens, such as the organization of emergency services and emergency services (38%) and hospital assistance (25%). “HPV infections are widespread. Approximately 80% of the population can contract these viruses and can be the source of potential tumors. It is absolutely important that the population goes away because we know that it gives almost total protection against these diseases. Adhesion to vaccination in Italy is still low and we must relaunch the effort to ensure an offer that facilitates access to the vaccination itself”, says Enrico Di Rosa, president of the Italian Society of Hygiene. There is also an increase in demand for a more incisive role of the State, not to replace the Regions but to ensure uniform standards and reduce territorial inequalities. Italian citizens express confidence in innovation, recognizing in investments in Research & Development a decisive factor that has led to more effective therapies, early diagnosis, advanced diagnostics, modern surgery, while creating a positive impact on the country’s economy. “The equity of innovation is the key point for new drugs to be accessible to all. We must continue to work so that innovation becomes central in health investments. The lines that the regional administration is carrying out aiming to bring back the attractive territory for so many companies”, says Antonello Aurigemma, president of the Regional Council of Lazio. Another epidemic is that of chronic diseases. Research carried out by pharmaceutical companies is essential to improve the treatment and management of these pathologies and Patient Associations have an increasingly central role in the evaluation and access to therapeutic innovation. With significant advances in research, access to the therapies does not always follow the same pace. In fact, there are important regional differences in Italy and between the European countries, particularly with regard to rare diseases and orphan drugs. “To date we have plans that identify goals. To reach the most people, you need a national strategy with specific actions to increase the target of vaccinations. You can also offer vaccinesnation in other settings, involve the pediatricians of free choice and try to communicate in unison with how important vaccination is,” adds Caterina Rizzo, ordinary professor of Hygiene at the University of Pisa. MSD aspires to be the world’s first high-intensity research biopharmaceutical company and is at the forefront of offering innovative health solutions to support the prevention and treatment of diseases in people and animals. -photo mec/Italpress – (ITALPRESS).
